Feb 29, 2024 · Linzess is a prescription medicine used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults. Linzess is also used to treat functional constipation (FC) in children and adolescents 6 to 17 years of age.

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown.

Jul 22, 2024 · Linzess (linaclotide) is commonly used to treat constipation in people with certain bowel problems, including irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation,...

Jul 17, 2023 · Linzess (linaclotide) is used to treat chronic (long-term) constipation related to irritable bowel syndrome (IBS) and other unknown causes. It's a capsule that's taken by mouth once a day. There are pros and cons for taking this medication.

Apr 14, 2022 · Linzess (linaclotide) is a prescription capsule used to treat certain types of irritable bowel syndrome and constipation. Learn about side effects and more.

For relief from symptoms of IBS-C or CIC, take LINZESS as directed. Learn how to take LINZESS, a daily treatment for chronic constipation. See Important Risk Information and Boxed Warning.

Jun 26, 2023 · Linzess (linaclotide) is a guanylate cyclase-C agonist indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, chronic idiopathic constipation (CIC) in adults, and functional constipation (FC) in pediatric patients 6 to 17 years of age. What Are Side Effects of Linzess? Side effects of Linzess include:

LINZESS® (linaclotide) is a prescription medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in children and adolescents 6 to 17 years of age. “Idiopathic” means the cause of the constipation is unknown.

LINZESS® (linaclotide) is indicated for managing Irritable Bowel Syndrome with Constipation, Chronic Idiopathic Constipation in adults, and Functional Constipation in patients 6 to 17 years of age. See Important Safety Information and Prescribing Information.

LINZESS® (linaclotide) is available in a once-daily dose for adults with IBS-C or CIC, and pediatric patients with Functional Constipation. See Important Safety Information and Prescribing Information.